Sinopharm
1099.HK
#2698
Rank
โ‚น601.07 B
Marketcap
โ‚น192.61
Share price
3.52%
Change (1 day)
-12.25%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: โ‚น601.07 Billion

As of October 2026 Sinopharm has a market cap of โ‚น601.07 Billion. This makes Sinopharm the world's 2698th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น601.07 B-14.63%
2025โ‚น704.06 B-6.57%
2024โ‚น753.60 B10.77%
2023โ‚น680.33 B3.48%
2022โ‚น657.42 B30.13%
2021โ‚น505.20 B-4.25%
2020โ‚น527.61 B-31.84%
2019โ‚น774.11 B-11.32%
2018โ‚น872.97 B14.27%
2017โ‚น763.97 B-1.38%
2016โ‚น774.69 B4.99%
2015โ‚น737.85 B18.89%
2014โ‚น620.64 B36.32%
2013โ‚น455.27 B10.62%
2012โ‚น411.56 B34.88%
2011โ‚น305.13 B-13.65%
2010โ‚น353.36 B-5.35%
2009โ‚น373.34 B